PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 92 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $39,000 | -27.8% | 11,434 | -0.7% | 0.00% | – |
Q2 2019 | $54,000 | +38.5% | 11,510 | -1.5% | 0.00% | – |
Q1 2019 | $39,000 | +34.5% | 11,689 | +7.9% | 0.00% | – |
Q4 2018 | $29,000 | -97.2% | 10,833 | -94.1% | 0.00% | -100.0% |
Q3 2018 | $1,036,000 | +20.0% | 184,931 | +8.6% | 0.00% | 0.0% |
Q2 2018 | $863,000 | -32.5% | 170,254 | -9.2% | 0.00% | 0.0% |
Q1 2018 | $1,278,000 | – | 187,402 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |